Suppr超能文献

胶质细胞源性神经营养因子(GDNF)和神经营养因子-3(NTN)脑内输注的药代动力学和生物活性。

Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain.

机构信息

Laboratory of Molecular Therapeutics, Department of Neurosurgery, University of California San Francisco, CA 94103, USA.

出版信息

Neuropharmacology. 2010 Jun;58(7):1114-21. doi: 10.1016/j.neuropharm.2010.02.002. Epub 2010 Feb 11.

Abstract

Convection-enhanced delivery (CED) of GDNF and NTN was employed to determine the tissue clearance of these factors from the rat striatum and the response of the dopaminergic system to a single infusion. Two doses of GDNF (15 and 3 microg) and NTN (10 microg and 2 microg) were infused into the rat striatum. Animals were euthanized 3, 7, 14, 21, and 28 days post-infusion. Brains were processed for ELISA, HPLC, and immunohistochemistry (IHC). Both doses of the infused GDNF resulted in a sharp increase in striatal GDNF levels followed by a rapid decrease between day 3 and 7. Interestingly, IHC revealed GDNF in the septum and the base of the brain 14 days after GDNF administration. Dopamine (DA) turnover was significantly increased in a dose-dependent manner for more than 7 days after a single GDNF infusion. NTN persisted in the brain for at least two weeks longer than GDNF. It also had more persistent effects on DA turnover, probably due to its precipitation in the brain at neutral pH after infusion. Our data suggest that daily or continuous dosing may not be necessary for delivering growth factors into the CNS.

摘要

通过对流增强递送 (CED) 技术将 GDNF 和 NTN 递送至大鼠纹状体,以确定这些因子从大鼠纹状体中的组织清除率,以及多巴胺能系统对单次输注的反应。将两种剂量的 GDNF(15 和 3μg)和 NTN(10μg 和 2μg)输注到大鼠纹状体中。动物在输注后 3、7、14、21 和 28 天被安乐死。对大脑进行 ELISA、HPLC 和免疫组织化学 (IHC) 分析。两种剂量的输注 GDNF 导致纹状体 GDNF 水平急剧增加,随后在第 3 天至第 7 天迅速下降。有趣的是,在 GDNF 给药后 14 天,IHC 显示 GDNF 在隔室和大脑基底。单次 GDNF 输注后,多巴胺 (DA) 周转率呈剂量依赖性显著增加,持续时间超过 7 天。NTN 在大脑中的持续时间比 GDNF 长至少两周。这可能是由于输注后在中性 pH 值下在大脑中沉淀,因此对 DA 周转率的持续作用也更长。我们的数据表明,每天或连续给药可能不是将生长因子递送至中枢神经系统所必需的。

相似文献

1
Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain.
Neuropharmacology. 2010 Jun;58(7):1114-21. doi: 10.1016/j.neuropharm.2010.02.002. Epub 2010 Feb 11.
2
Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNF.
Neurochem Res. 2010 May;35(5):727-34. doi: 10.1007/s11064-010-0128-0. Epub 2010 Jan 30.
3
Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
Neurochem Int. 2010 Nov;57(5):540-6. doi: 10.1016/j.neuint.2010.06.019. Epub 2010 Jul 6.
4
GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution.
Neuropharmacology. 2019 Mar 15;147:28-36. doi: 10.1016/j.neuropharm.2018.05.014. Epub 2018 May 29.
5
Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor.
Exp Neurol. 1999 Nov;160(1):235-43. doi: 10.1006/exnr.1999.7175.
9
Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
Exp Neurol. 2009 Sep;219(1):197-207. doi: 10.1016/j.expneurol.2009.05.013. Epub 2009 May 19.

引用本文的文献

2
Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling.
Cell Mol Neurobiol. 2023 Oct;43(7):3179-3189. doi: 10.1007/s10571-023-01375-z. Epub 2023 Jul 6.
3
Neurotrophic factor-based pharmacological approaches in neurological disorders.
Neural Regen Res. 2023 Jun;18(6):1220-1228. doi: 10.4103/1673-5374.358619.
4
Neurotrophins as Therapeutic Agents for Parkinson's Disease; New Chances From Focused Ultrasound?
Front Neurosci. 2022 Mar 25;16:846681. doi: 10.3389/fnins.2022.846681. eCollection 2022.
5
Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain.
Curr Res Pharmacol Drug Discov. 2020 May 6;1:19-29. doi: 10.1016/j.crphar.2020.04.001. eCollection 2020 Apr.
6
Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's Disease.
Int J Toxicol. 2021 Jan-Feb;40(1):4-14. doi: 10.1177/1091581820966315. Epub 2020 Nov 2.
7
Improving therapeutic potential of GDNF family ligands.
Cell Tissue Res. 2020 Oct;382(1):173-183. doi: 10.1007/s00441-020-03256-z. Epub 2020 Jul 28.
8
Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease.
Mov Disord. 2019 Jul;34(7):1073-1078. doi: 10.1002/mds.27724. Epub 2019 May 30.
9
Amelioration of the nigrostriatal pathway facilitated by ultrasound-mediated neurotrophic delivery in early Parkinson's disease.
J Control Release. 2019 Jun 10;303:289-301. doi: 10.1016/j.jconrel.2019.03.030. Epub 2019 Apr 4.

本文引用的文献

2
5
Absolute requirement of GDNF for adult catecholaminergic neuron survival.
Nat Neurosci. 2008 Jul;11(7):755-61. doi: 10.1038/nn.2136. Epub 2008 Jun 8.
9
Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension.
Science. 2007 Mar 2;315(5816):1243-9. doi: 10.1126/science.1136281. Epub 2007 Feb 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验